Networking dinner In order to reserve your seat download the booking form in the link below and fax back to +44 (0) 207 242 1508. The meal costs $100 per person - places limited Download booking form Key speakers include: Dr Jon Andrus Chief, Immunisation Programme PAHO Dr Peter Paradiso Vice President Wyeth Vaccines Dr Luc Hessel Executive Director, Medical and Public Affairs, Europe Sanofi Pasteur MSD Dr Derek O'Hagan Vice President Novartis Vaccines and Diagnostics Dr Jeffrey Ulmer Head Immunology and Cell Biology Novartis Vaccines and Diagnostics Dr Allan Jarvis Senior Vice President Aventis Pasteur Dr Kathleen Coelingh Senior Director, Scientific Affairs MedImmune Vaccines Dr KV Balasubramaniam Managing Director Indian Immunologicals Dr Max Ciarlet Associate Director, Vaccine & Biologics - Clinical Research Department, Merck Research Laboratories Download the conference brochure now >>>       Exhibition hall sold out - apply to Edward Low for alternative sponsorship opportunities The World Vaccine Congress is the definitive strategic meeting place for the vaccine industry in the United States, Canada, as well as Central and South America. World Vaccine Congress is a rare opportunity to gain insight into the business of the future. The event brings together all major players in this industry. World Vaccine Congress is a great opportunity in a time of great change. Register NOW! Question the experts! Bring plenty of business cards! Research advances herald a vaccine revival   After years of relative dormancy, vaccines are continuing their remarkable comeback. Spurred on by increased public health issues such as the threat of bio-terrorism and emerging diseases such as bird flu and other infectious diseases, the vaccine industry has received a much needed shot in the arm. With vaccines threatening to outpace drugs in terms of sales growth over the coming years, the financial prospects for the vaccine business have never looked better.   After largely abandoning the business because of low prices, tight regulations and fear of lawsuits, vaccine manufacturers have been busily re-evaluating their investment in vaccines. Tied in with renewed governmental and philanthropic support for furthering scientific research and for the purchase of vaccines with increased funding, interest in vaccine development has continued to grow.   Bringing together the leading minds of the vaccine community Register NOW! Updates on global vaccine news Hear thought provoking presentations Addiitional speakers to have confirmed their participation include: Michel Zaffran, Deputy Executive Secretary and Chief Technical and Policy Officer, Global Alliance for Vaccines and Immunization Dr Max Ciarlet, Associate Director, Vaccine & Biologics - Clinical Research Department, Merck Research Laboratories Dr Beatrice de Vos, Head Global Medical Affairs, GlaxoSmithKline Dr Eliav Barr, Head of Biological Clinical Research, Merck & Co. Jacques Francois Martin, President, Parteurop Click here for the full speakers list > The revival of the vaccine industry, which was once dismissed as a low-margin and commoditised business by many big drug makers, is due in part to a series of key innovations involving prophylactic and therapeutic novel disease targets. Recent scientific progress has also opened up many new opportunities through the development of innovative drug delivery mechanisms and new adjuvants.   With the new developments in disease applications and the availability of biotechnological tools, the ever growing challenges of regulation, feasibility, clinical development and funding are all very much at the forefront of vaccine developers’ priorities. Bringing together the leading minds in the vaccine community, the World Vaccine Congress will present you with the solutions to these and many more challenges. World Vaccine Congress is your must attend vaccines event in 2007 Register today by calling +44 (0)20 7242 2324 or register securely online - click here To discuss speaking and sponsorship opportunities please contact:  Edward Low Project Manager, on +44 (0) 20 7827 5994 or email edward.low@terrapinn.com